Healthcare -
Biotechnology - NASDAQ - US
$ 14.13
-4.33 %
$ 1.44 B
Market Cap
-3.95
P/E
DYN - TOTAL EQUITY
Total Equity DYN - Dyne Therapeutics, Inc.
91.3 M
LAST VALUE
-50.21%
2 YEAR CAGR
83.33%
5 YEAR CAGR
-27.29%
10 YEAR CAGR